Anti-Human CSPG5 Antibody (CSPG5202) from ProteoGenix; catalogue ARO-A22771; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human CSPG5 Antibody (CSPG5202) is a highly specific and reliable tool for studying chondroitin sulfate proteoglycan 5 (CSPG5) in human tissues. This unique antibody is produced using advanced biotechnology methods and has been extensively validated for its specificity and sensitivity in detecting CSPG5.
CSPG5 is a protein that is primarily found in the extracellular matrix of various tissues, including the brain, heart, and lungs. It plays a crucial role in cell adhesion, migration, and signaling, making it a key player in various biological processes.
One of the main applications of the Anti-Human CSPG5 Antibody is in research related to cancer. Studies have shown that CSPG5 is overexpressed in several types of cancer, including breast, lung, and colon cancer. This makes it a potential biomarker for cancer diagnosis and a promising target for cancer treatment.
Another important use case for this antibody is in neurological research. CSPG5 has been found to be involved in the development and maintenance of the central nervous system, making it a potential target for neurological disorders such as Alzheimer’s disease and multiple sclerosis.
In addition to its main applications, the Anti-Human CSPG5 Antibody has also been used in various experimental settings, including immunohistochemistry, Western blotting, and flow cytometry. Its high specificity and sensitivity make it a valuable tool for studying CSPG5 in different tissues and cell types.
With its advanced technology and extensive validation, the Anti-Human CSPG5 Antibody (CSPG5202) is a reliable and versatile tool for researchers studying CSPG5 in various biological contexts. Its use can lead to a better understanding of the role of CSPG5 in cancer, neurological disorders, and other biological processes, ultimately contributing to the development of new diagnostic and therapeutic strategies. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22771. For research use only.
Target: CSPG5; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
